ppeptidewhy
Side by side

Compare peptides.

See why people discuss them, what the evidence supports, and where amount information comes from.

Choose two compounds

Add up to four if you need to. Evidence labels apply to specific claims and products.

Compare more (up to four)

Growth hormone

Tesamorelin

A compound that copies the action of a hormone that signals the release of growth hormone. It has been studied in medicinal products.

Why people are interested

Tesamorelin is known because an approved prescription product reduces excess abdominal fat in adults with HIV-associated lipodystrophy. People also discuss it for general body composition.

What the research supports

EGRIFTA WR has a specific FDA-approved indication. Its label states it is not indicated for weight-loss management; clinical findings do not validate a research vial.

Clinical or label amounts

Prescription product label

1.28 mg

Once daily for EGRIFTA WR

Specific to the named study or medicine, not this research vial.

EGRIFTA WR prescribing information ↗

Publicly reported amounts

Amount in one post: eventually about 1.2–1.5 mg tesamorelin with about 350 mcg ipamorelin

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full Tesamorelin profile and sources →
Metabolic & appetite

Tirzepatide

Tirzepatide acts on GIP and GLP-1 receptors. It has been studied in human medicine products for blood sugar and metabolic effects.

Why people are interested

Tirzepatide is well known because prescription versions are used for type 2 diabetes, chronic weight management, and certain sleep-apnea patients. JD-2TR is a seller code associated with tirzepatide in listed batch reports.

What the research supports

The strongest evidence belongs to manufactured prescription tirzepatide products studied in clinical trials. FDA approval applies to those products and specific indications, not automatically to a research-only JD-2TR vial.

Clinical or label amounts

Prescription product label

2.5–15 mg

Once weekly in adults

Specific to the named study or medicine, not this research vial.

Mounjaro prescribing information (2026) ↗

Publicly reported amounts

Amount in one post: 2.5 mg each time from a stated 10 mg dry vial

One checked post, not a typical amount or a recommendation.

Public reports and source limits →
Read the full Tirzepatide profile and sources →

FDA-approved uses belong to named prescription products and indications; they do not transfer to an online research vial. Human, animal, cell, and anecdotal evidence are different. How we check sources →